Menopause
Latest News
PCPs facing increased patient demand for knowledgeable menopause care
More patient demand for HT shining a light on inadequate primary care training in menopause medicine.
Feature
Underprescribed menopause relief: Women suffer needlessly
Treating with low-dose estrogen isn’t a radical approach – in fact, it is the standard of care for women experiencing many menopause symptoms.
From the Journals
Progesterone might benefit women in perimenopause
The best management for symptoms in perimenopause is an often-neglected topic of research.
From the Journals
HT, even short-term use, linked to dementia risk in women
Short-term and cyclical use of estrogen and progestin therapy for menopausal symptoms is linked to an increased risk of dementia.
Commentary
Does ‘skeletal age’ describe fracture impact on mortality?
Mortality risk may be related to patients not fully understanding the consequence of a fragility fracture.
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
Commentary
A new nonhormonal option for menopausal hot flashes: What prescribers should know
In two phase 3 clinical trials, fezolinetant 45 mg reduced the frequency of vasomotor symptoms by about 65%.
From the Journals
Hormone therapies still ‘most effective’ in treating menopausal vasomotor symptoms
Clinicians should individualize menopause care to each patient.
From the Journals
Nitroglycerin patches do not improve menopause symptoms
“The menopause field is still lacking in effective treatment approaches that don’t involve hormones,” said Dr. Alison Huang.
Feature
Menopause and long COVID: What women should know
Women at midlife who have long COVID seem to get specific, and severe, symptoms, including brain fog, fatigue, new-onset dizziness, and difficulty...
Latest News
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.